m 6 A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia.
Yanchun ZhaoYutong ZhouYu QianWenwen WeiXiangjie LinShihui MaoJie SunJie JinPublished in: Clinical and translational medicine (2024)
A modification, elucidate the regulatory mechanisms of IGF2BP2 and IGF2BP3 on DDX21, and reveal the underlying roles of DDX21 in AML.